Drug Res (Stuttg) 2022; 72(05): 255-258
DOI: 10.1055/a-1785-3936
DOI: 10.1055/a-1785-3936
Original Article
A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
Authors
-
Zhanna Buzitskaya
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII) -
Kira Stosman
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII) -
Berik Khairullin
2 The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK) -
Marhabat Kassenov
2 The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK) -
Ainur Nurpeisova
2 The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK) -
A. Abylai Sansyzbay
2 The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK) -
Anna-Polina Shurygina
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII) -
Andrey Aleksandrov
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII) -
Konstantin Sivak
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII) -
Marina Stukova
1 Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)

